DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,494,920 | +5.7% | 243,882 | +2.3% | 0.28% | +7.6% |
| Q2 2023 | $57,241,200 | -5.1% | 238,505 | -0.3% | 0.26% | -16.7% |
| Q1 2023 | $60,295,025 | -2.9% | 239,228 | +2.3% | 0.32% | -12.2% |
| Q4 2022 | $62,082,535 | +6.8% | 233,903 | +4.0% | 0.36% | -2.4% |
| Q3 2022 | $58,106,000 | +12.8% | 224,966 | +10.8% | 0.37% | +16.4% |
| Q2 2022 | $51,496,000 | -13.1% | 203,126 | +0.5% | 0.32% | -1.5% |
| Q1 2022 | $59,290,000 | -9.7% | 202,124 | +1.3% | 0.32% | -2.7% |
| Q4 2021 | $65,635,000 | +24.6% | 199,492 | +15.3% | 0.33% | +11.8% |
| Q3 2021 | $52,676,000 | +32.5% | 173,024 | +16.8% | 0.30% | +29.1% |
| Q2 2021 | $39,753,000 | +21.6% | 148,131 | +2.0% | 0.23% | +10.6% |
| Q1 2021 | $32,691,000 | -69.5% | 145,244 | -69.9% | 0.21% | -71.2% |
| Q4 2020 | $107,147,000 | -0.9% | 482,335 | -3.9% | 0.72% | -13.1% |
| Q3 2020 | $108,088,000 | +80.7% | 501,962 | +48.4% | 0.83% | +64.0% |
| Q2 2020 | $59,809,000 | +7.7% | 338,232 | -15.7% | 0.51% | -11.8% |
| Q1 2020 | $55,528,000 | +6.5% | 401,188 | +18.1% | 0.57% | +22.9% |
| Q4 2019 | $52,155,000 | +1.8% | 339,820 | -4.2% | 0.47% | -4.5% |
| Q3 2019 | $51,217,000 | +21.6% | 354,616 | +20.4% | 0.49% | +17.5% |
| Q2 2019 | $42,106,000 | -9.7% | 294,607 | -16.6% | 0.42% | -9.2% |
| Q1 2019 | $46,619,000 | +16.5% | 353,129 | -9.0% | 0.46% | +2.5% |
| Q4 2018 | $40,005,000 | +280.1% | 387,948 | +300.5% | 0.45% | +338.2% |
| Q3 2018 | $10,524,000 | +6.7% | 96,861 | -3.1% | 0.10% | 0.0% |
| Q2 2018 | $9,866,000 | -11.9% | 99,982 | -12.6% | 0.10% | -16.4% |
| Q1 2018 | $11,204,000 | +10.2% | 114,432 | +4.5% | 0.12% | +3.4% |
| Q4 2017 | $10,168,000 | +12.6% | 109,545 | +4.0% | 0.12% | +0.9% |
| Q3 2017 | $9,034,000 | +6.2% | 105,307 | +4.4% | 0.12% | +2.6% |
| Q2 2017 | $8,510,000 | -0.9% | 100,840 | +0.4% | 0.11% | -5.8% |
| Q1 2017 | $8,588,000 | +15.9% | 100,412 | +5.5% | 0.12% | -9.0% |
| Q4 2016 | $7,410,000 | +21.9% | 95,174 | +22.7% | 0.13% | +22.0% |
| Q3 2016 | $6,081,000 | -18.9% | 77,574 | +3.1% | 0.11% | -22.1% |
| Q2 2016 | $7,501,000 | +4.6% | 75,223 | -0.5% | 0.14% | +2.2% |
| Q1 2016 | $7,172,000 | +12.9% | 75,603 | +10.6% | 0.14% | +11.4% |
| Q4 2015 | $6,352,000 | +9.7% | 68,388 | +0.6% | 0.12% | +6.0% |
| Q3 2015 | $5,791,000 | -1.8% | 67,957 | -1.4% | 0.12% | +6.4% |
| Q2 2015 | $5,897,000 | +1.8% | 68,902 | +1.0% | 0.11% | +5.8% |
| Q1 2015 | $5,790,000 | -1.9% | 68,202 | -0.4% | 0.10% | 0.0% |
| Q4 2014 | $5,903,000 | +9.0% | 68,452 | -4.0% | 0.10% | +7.3% |
| Q3 2014 | $5,418,000 | -2.0% | 71,302 | +1.6% | 0.10% | -5.9% |
| Q2 2014 | $5,527,000 | +5.4% | 70,202 | +0.4% | 0.10% | +6.2% |
| Q1 2014 | $5,246,000 | -9.9% | 69,942 | -7.3% | 0.10% | -8.6% |
| Q4 2013 | $5,825,000 | +7.7% | 75,452 | -3.3% | 0.10% | +2.9% |
| Q3 2013 | $5,408,000 | -9.2% | 78,012 | -17.1% | 0.10% | -13.6% |
| Q2 2013 | $5,957,000 | – | 94,114 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |